About MC Pirogov
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MC Pirogov
During the past decade, MC Pirogov conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer
2012-05-01
2015-03-01
Completed
371
A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer
2012-08-01
2018-05-01
Completed
770
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MC Pirogov
According to Clinical.Site data, the most researched conditions in "MC Pirogov" are
"Chronic Rhinosinusitis" (2 trials). Many other conditions were trialed in "MC Pirogov" in a lesser frequency.
Clinical Trials Intervention Types at MC Pirogov
Most popular intervention types in "MC Pirogov" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "OPN-375" (2 trials). Other intervention names were less common.
Clinical Trials Genders at MC Pirogov
The vast majority of trials in "MC Pirogov" are
2 trials for "All" genders.
Clinical Trials Status at MC Pirogov
Currently, there are NaN active trials in "MC Pirogov".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in MC Pirogov,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MC Pirogov, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".